Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Maha Properti Indonesia Tbk. (MPRO) Price & Performance

UBC Medical Indonesia Tbk.Trade
Maha Properti Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Maha Properti Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Maha Properti Indonesia Tbk. trades at Rp12,000 (market cap 114.34T, 4.4K 24h volume). The key difference: Maha Properti Indonesia Tbk. is far larger — about 179.8× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 4.4K). Which is the better fit depends on your goals.

LABSMPRO
Market Cap
635.95B114.34T
Volume
843K4.4K
Lot
8.43K44
Turnover
137.6M51.32M
Average Price
163.2211,663.07
Value
137.6M51.32M
Indicative Equilibrium Price
16512,000
Indicative Equilibrium Volume
2461

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MPRO
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Maha Properti Indonesia Tbk.

PT Propertindo Mulia Investama Tbk (formerly PT Agro Mulia Investama) (the Entity) was established based on Notarial Deed No. 2 of Notary Benediktus Andy Widyanto, S.H., dated March 5, 2004.

Read more on MPRO